Cel
Despite the increasing number of macromolecules with potential impact in the treatment of devastating systemic diseases, these therapies have failed to deliver on their expectations because they cannot be administered in the fashion which is most cost efficient and has the highest patient compliance: the oral route. The availability of an oral form of administration could lead to a great improvement of classical therapies and it would also make a high number of new therapies feasible. To make this happen, the final objective of Trans-INT is to design nanocarriers specifically adapted to deal with the gastrointestinal ecosystem and use them for the development of new oral nanomedicines for diseases with high socioeconomic impact (i.e. metabolic diseases, pain medication).
The concept behind TRANS-INT is the rational design of oral nanomedicines based on safety, mechanistic, bioengineering (multifunctional nanocarriers: high payload, drug protection, efficient drug transport, controlled release) and pharmaceutical technology criteria (scalable technology and stability). The project will start with nanocarrier platforms on which the partners have IPR and freedom to operate: nanocapsules, nanoparticles, micelles made of combinations of lipids, polypeptides and polysaccharides, continue with the optimization and redefinition of selected nanocarriers. It is expected to end with (i) at least one oral nanocarrier prototype with a comprehensive GLP-tox package, which could be applied for the delivery of a high number of peptide molecules, (ii) at least one nanomedicine fulfilling target product profile criteria, with a comprehensive preclinical evaluation package, (iii) substantial integrative knowledge on the feasibility and potential of oral nanocarriers and nanopharmaceuticals. TRANS-INT is expected to have a great impact no only from the new therapies/patients perspective but also from the innovation and EU industrial development perspective.
Dziedzina nauki
- medical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugs
- natural sciencesbiological sciencesbiochemistrybiomoleculeslipids
- medical and health sciencesmedical biotechnologynanomedicine
- natural sciencesbiological sciencesbiochemistrybiomoleculescarbohydrates
- engineering and technologynanotechnologynano-materials
Zaproszenie do składania wniosków
FP7-NMP-2011-LARGE-5
Zobacz inne projekty w ramach tego zaproszenia
System finansowania
CP-IP - Large-scale integrating projectKoordynator
15782 Santiago De Compostela
Hiszpania
Zobacz na mapie
Uczestnicy (17)
4 Dublin
Zobacz na mapie
1348 Louvain La Neuve
Zobacz na mapie
75015 PARIS 15
Zobacz na mapie
WC1E 6BT LONDON
Zobacz na mapie
Zakończenie uczestnictwa
08028 Barcelona
Zobacz na mapie
Zakończenie uczestnictwa
35131 Padova
Zobacz na mapie
9 DUBLIN
Zobacz na mapie
49035 Angers Cedex 01
Zobacz na mapie
30625 Hannover
Zobacz na mapie
08028 Barcelona
Zobacz na mapie
751 05 Uppsala
Zobacz na mapie
35128 Padova
Zobacz na mapie
1125 Budapest
Zobacz na mapie
94250 GENTILLY
Zobacz na mapie
Zakończenie uczestnictwa
4070 Basel
Zobacz na mapie
T12 YN60 Cork
Zobacz na mapie
36030 Monte Di Malo
Zobacz na mapie